HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-Hee Suh Selected Research

Adult-Onset Still's Disease

5/2022Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature.
1/2022Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still's disease.
12/2021An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.
2/2021Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease.
1/2020Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.
11/2019The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
1/2019The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease.
1/2018Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease.
1/2017Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
1/2017Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-Hee Suh Research Topics

Disease

37Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 02/2003
31Rheumatoid Arthritis
12/2021 - 01/2007
17Adult-Onset Still's Disease
05/2022 - 11/2003
15Inflammation (Inflammations)
11/2021 - 06/2004
8Asthma (Bronchial Asthma)
12/2006 - 06/2004
7Ankylosing Spondylitis
05/2022 - 08/2012
6Infections
01/2019 - 06/2006
5Osteoporosis
05/2022 - 11/2017
5Thrombocytopenia (Thrombopenia)
02/2022 - 01/2015
5Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2021 - 07/2012
4Autoimmune Diseases (Autoimmune Disease)
12/2021 - 02/2003
4Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021 - 01/2017
4Nephritis
01/2021 - 09/2007
3Necrosis
05/2022 - 05/2015
3Arthritis (Polyarthritis)
01/2021 - 08/2014
3Rheumatic Diseases (Rheumatism)
01/2021 - 01/2018
3Immune System Diseases (Immune Disorders)
02/2020 - 10/2019
3Serositis
01/2019 - 01/2010
2Osteoporotic Fractures
05/2022 - 12/2018
2Fever (Fevers)
02/2022 - 12/2017
2Vasculitis (Vasculitides)
12/2021 - 12/2018
2Proteinuria
01/2021 - 05/2018
2Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
07/2020 - 01/2012
2Tuberculosis (Tuberculoses)
06/2020 - 01/2016
2Alopecia (Baldness)
12/2019 - 08/2014
2Skin Manifestations
11/2019 - 01/2017
2Atherosclerosis
08/2019 - 01/2019
2Lupus Nephritis
01/2019 - 05/2018
2Hypertriglyceridemia
11/2018 - 01/2015
2Exanthema (Rash)
01/2017 - 08/2016
2Leukopenia
01/2015 - 08/2008
2Joint Diseases (Joint Disease)
09/2012 - 07/2006
2Disease Susceptibility (Diathesis)
11/2010 - 10/2009
2Urticaria (Hives)
12/2005 - 06/2005
1COVID-19
05/2022
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2022
1Thrombotic Thrombocytopenic Purpura
02/2022
1Hemolytic Anemia
02/2022
1Abdominal Pain (Pain, Abdominal)
08/2021
1Amyloidosis
08/2021
1Diarrhea
08/2021
1Sarcopenia
08/2021

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2007
13Biosimilar PharmaceuticalsIBA
10/2021 - 01/2017
11Rituximab (Mabthera)FDA Link
02/2022 - 01/2012
10C-Reactive ProteinIBA
05/2022 - 06/2006
8GlucocorticoidsIBA
05/2022 - 11/2017
8CT-P10IBA
12/2020 - 01/2017
7Pharmaceutical PreparationsIBA
05/2022 - 01/2015
6AntibodiesIBA
02/2022 - 09/2004
6Interleukin-6 (Interleukin 6)IBA
08/2021 - 06/2006
5Antirheumatic Agents (DMARD)IBA
08/2021 - 07/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2021 - 08/2012
5CytokinesIBA
01/2020 - 11/2003
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2007 - 09/2005
4Biological ProductsIBA
05/2022 - 01/2020
4Tumor Necrosis Factor InhibitorsIBA
05/2022 - 01/2016
4Complement System Proteins (Complement)IBA
01/2021 - 08/2008
4AutoantibodiesIBA
01/2015 - 06/2006
4Immunoglobulin E (IgE)IBA
02/2007 - 07/2003
4Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA
12/2006 - 06/2004
3Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2014
3Peptides (Polypeptides)IBA
11/2021 - 02/2003
3Toll-Like Receptors (Toll-Like Receptor)IBA
11/2021 - 01/2020
3Infliximab (Remicade)FDA Link
10/2021 - 06/2017
3AlbuminsIBA
02/2021 - 10/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 07/2006
3LigandsIBA
01/2020 - 01/2010
3anti-dsDNA autoantibodyIBA
12/2019 - 08/2008
3HLA Antigens (Human Leukocyte Antigens)IBA
10/2019 - 01/2018
3Interleukin-10 (Interleukin 10)IBA
03/2008 - 06/2006
3EnzymesIBA
01/2006 - 09/2004
2AutoantigensIBA
12/2021 - 09/2004
2Salivary Proteins and PeptidesIBA
11/2021 - 01/2021
2Immunoglobulins (Immunoglobulin)IBA
11/2021 - 01/2021
2CT-P13IBA
10/2021 - 06/2020
2tocilizumab (atlizumab)FDA Link
08/2021 - 12/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2014
2Protein SIBA
01/2019 - 01/2010
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2019 - 05/2018
2Transcription Factors (Transcription Factor)IBA
01/2019 - 12/2018
2growth arrest-specific protein 6IBA
06/2014 - 01/2013
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2012 - 01/2006
2Methacholine Chloride (Methacholine)FDA Link
10/2006 - 06/2006
2Immunoglobulin G (IgG)IBA
06/2006 - 09/2004
1BNT162 VaccineIBA
05/2022
1Messenger RNA (mRNA)IBA
05/2022
1VaccinesIBA
05/2022
1thiamine triphosphorate (TTP)IBA
02/2022
1Toll-Like Receptor 1IBA
01/2022
1Calcium-Binding ProteinsIBA
01/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2021
1Amyloid (Amyloid Fibrils)IBA
08/2021
1AA amyloidosisIBA
08/2021
1GlobulinsIBA
02/2021
1Ferritins (Ferritin)IBA
02/2021

Therapy/Procedure

11Therapeutics
05/2022 - 05/2012
2Biological Therapy
08/2021 - 08/2017
2Drug Therapy (Chemotherapy)
09/2012 - 07/2006
1Plasmapheresis
02/2022